DCMPDiabetes Management Program with CGM and Remote Monitoring in Underserved Clinics
Continuous glucose monitor (CGM)
Diabetes Mellitus+3
+ Diabetes Mellitus, Type 2
+ Endocrine System Diseases
Treatment Study
Summary
Study start date: March 18, 2025
Actual date on which the first participant was enrolled.This study aims to develop a program to better manage diabetes in underserved communities by using technology, specifically continuous glucose monitors (CGM) and remote patient monitoring (RPM). These tools help provide a clearer picture of blood sugar levels, which is crucial for adjusting treatment plans. The study focuses on people visiting safety net clinics, often experiencing higher rates of diabetes complications. The goal is to improve glucose control and reduce stress related to diabetes, ultimately enhancing both patient and healthcare provider satisfaction. With more clinics offering telehealth services, this program has the potential to be used more widely, benefiting many people who might otherwise struggle to manage their diabetes effectively. Participants in the study will use CGMs to track their blood sugar continuously. They will also take part in experiments to see how food and exercise affect their glucose levels. Follow-ups with their healthcare team are scheduled to review this data and adjust treatments if necessary. Those needing insulin will wear the CGM throughout the study, while others will use it for the first 12 weeks and then intermittently. The study includes weekly monitoring of the RPM dashboard to ensure participants maintain their glucose levels within a healthy range. Educational support for both patients and healthcare providers is part of the program, with ongoing advice from endocrinology experts available to assist the primary care providers. This integrated approach aims to empower patients and healthcare providers, making diabetes management more effective and less stressful.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.40 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Community Health Center of Franklin County
Greenfield, United StatesOpen Community Health Center of Franklin County in Google Maps